Evidence map›Paper›PMID 25728776›Full record

ArticleAmerican journal of human genetics2015

Mutations in the NHEJ component XRCC4 cause primordial dwarfism.

Jennie E Murray, Mirjam van der Burg, Hanna IJspeert, Paula Carroll, Qian Wu, Takashi Ochi, Andrea Leitch, Edward S Miller, Boris Kysela, Alireza Jawad and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. DNA damage and repair: underlying mechanisms leading to microcephaly.Frontiers in cell and developmental biology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 8 countries.

Jennie E MurrayMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Mirjam van der BurgDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 Rotterdam, the Netherlands.
Hanna IJspeertDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 Rotterdam, the Netherlands.
Paula CarrollMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Qian WuDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Takashi OchiDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Andrea LeitchMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Edward S MillerSchool of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Boris KyselaSchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK.
Alireza JawadDepartment of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 Rotterdam, the Netherlands.
Armand BottaniDepartment of Genetic Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland.
Francesco BrancatiDepartment of Medical, Oral and Biotechnological Sciences, Gabriele D'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
Marco CappaEndocrinology and Diabetes Unit, IRCCS Bambino Gesù Children's Hospital, 00165 Rome, Italy.
Valerie Cormier-DaireDepartment of Genetics, INSERM UMR 1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, Hôpital Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris 75015, France.
Charu DeshpandeDepartment of Genetics, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Eissa A FaqeihChildren's Specialist Hospital, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
Gail E GrahamDepartment of Genetics, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.
Emmanuelle RanzaDepartment of Genetic Medicine, University Hospitals of Geneva, 1205 Geneva, Switzerland.
Tom L BlundellDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Andrew P JacksonMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. Electronic address: andrew.jackson@igmm.ed.ac.uk.
Grant S StewartSchool of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: g.s.stewart@bham.ac.uk.
Louise S BicknellMRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Erasmus MC · NLUniversity of Birmingham · GBUniversity of Cambridge · GBUniversity of Edinburgh · GBMRC Institute of Genetics and Molecular Medicine · GBUniversity Hospital of Geneva · CHBambino Gesù Children's Hospital · ITChildren's Hospital of Eastern Ontario · CAGuy's Hospital · GBHôpital Necker-Enfants Malades · FRKing Fahd Medical City · SAUniversity of Chieti-Pescara · IT

Funding

Cancer Research UK 13030Medical Research Council G0900034Medical Research Council MC_PC_U127580972Medical Research Council P/O O 088314Medical Research Council U127580972Wellcome Trust
6 · The paper itself

Abstract

Non-homologous end joining (NHEJ) is a key cellular process ensuring genome integrity. Mutations in several components of the NHEJ pathway have been identified, often associated with severe combined immunodeficiency (SCID), consistent with the requirement for NHEJ during V(D)J recombination to ensure diversity of the adaptive immune system. In contrast, we have recently found that biallelic mutations in LIG4 are a common cause of microcephalic primordial dwarfism (MPD), a phenotype characterized by prenatal-onset extreme global growth failure. Here we provide definitive molecular genetic evidence supported by biochemical, cellular, and immunological data for mutations in XRCC4, encoding the obligate binding partner of LIG4, causing MPD. We report the identification of biallelic mutations in XRCC4 in five families. Biochemical and cellular studies demonstrate that these alterations substantially decrease XRCC4 protein levels leading to reduced cellular ligase IV activity. Consequently, NHEJ-dependent repair of ionizing-radiation-induced DNA double-strand breaks is compromised in XRCC4 cells. Similarly, immunoglobulin junctional diversification is impaired in cells. However, immunoglobulin levels are normal, and individuals lack overt signs of immunodeficiency. Additionally, in contrast to individuals with LIG4 mutations, pancytopenia leading to bone marrow failure has not been observed. Hence, alterations that alter different NHEJ proteins give rise to a phenotypic spectrum, from SCID to extreme growth failure, with deficiencies in certain key components of this repair pathway predominantly exhibiting growth deficits, reflecting differential developmental requirements for NHEJ proteins to support growth and immune maturation.

Indexed as

MutationAllelesAmino Acid SequenceChildChild, PreschoolDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Ligase ATPDNA LigasesDwarfismDwarfism, PituitaryElectrophoresis, Gel, Pulsed-FieldExomeFaciesFemaleHumansDNA-Binding ProteinsDNA Ligase ATPDNA LigasesLIG4 protein, humanXRCC4 protein, human

Identifiers

PMID25728776
PMCPMC4375537
OpenAlexW2022373116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.